Clinical trial · Observational
Depression Screening in Patients Undergoing Radiation Therapy For Cancer
Efficiency of Screening for Depression in Cancer Patients Receiving Radiotherapy
NCT00951184CI-TRIAL-00017166completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Gathering information about depression in patients with cancer may help doctors learn more about the disease and plan the best treatment. PURPOSE: This clinical trial is studying depression screening in patients undergoing radiation therapy for cancer.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Depression | — | UNRESOLVED | — |
| Unspecified Adult Solid Tumor, Protocol Specific | Adult Solid Neoplasm | ALIAS | 0.85 |
Interventions
Interventions (5)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| assessment of therapy complications | Procedure | — | UNRESOLVED |
| psychosocial assessment and care | Procedure | — | UNRESOLVED |
| screening questionnaire administration | Other | — | UNRESOLVED |
| study of socioeconomic and demographic variables | Other | — | UNRESOLVED |
| telephone-based intervention | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Feasibility of a screening procedure for major depression
- timeFrame
- Within 1 week of registration
Secondary outcomes (8)
- measure
- Rates of major depression as identified in diagnostic telephone interviews
- timeFrame
- Within 4 weeks of registration
- measure
- False negative rate and false positive rate of the 9-item Patient Health Questionnaire (PHQ-9) and the 25-item Hopkins Symptom Checklist (HSCL-25)
- timeFrame
- Within 4 weeks of registration
- measure
- False negative rate of 2 items addressing mood disturbance on the PHQ-9 relative to all 9-items on the PHQ-9 and to the HSCL-25
- timeFrame
- Within 4 weeks of registration
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
Show eligibility criteria text
DISEASE CHARACTERISTICS: * Diagnosis of any tumor type * Scheduled to begin radiotherapy within 2 weeks * Stage I-IV cancer (where applicable) allowed * Pre-existing diagnosis of depression allowed PATIENT CHARACTERISTICS: * Zubrod performance status 0-1 * Able to speak and read English sufficiently to complete screening instruments * Must have existing land-line or cellular telephone service * Not considered suicidal, psychotic, or otherwise unfit for study participation by cancer center staff clinical judgment * No concurrent medical or psychiatric condition that, in the opinion of the investigator, would potentially pose a risk to the patient as a result of participation in this trial * Not mentally incompetent PRIOR CONCURRENT THERAPY: * See Disease Characteristics * Prior or concurrent combination therapy with surgery, chemotherapy, hormone therapy, or immunotherapy allowed * No concurrent psychotropic medication, psychotherapy, or pharmacotherapy for depression at screening * Not receiving hospice care
References
Publications (0)
Data not yet available
No reference posted for this study.